Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Colon Cancer With Resectable Liver Metastases”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Ended earlyNCT02738606
What this trial is testing

Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+5 more
M.D. Anderson Cancer Center 29
Not applicableLooking for participantsNCT04796818
What this trial is testing

An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverResectable Colorectal Carcinoma+4 more
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)UnknownNCT00438737
What this trial is testing

Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 100
Early research (Phase 1)Study completedNCT00059930
What this trial is testing

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 38
Large-scale testing (Phase 3)UnknownNCT00482222
What this trial is testing

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Southampton 340
Large-scale testing (Phase 3)UnknownNCT00006479
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Study completedNCT02754856
What this trial is testing

Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery

Who this might be right for
Metastatic Carcinoma in the LiverResectable MassStage IV Colorectal Cancer AJCC v7+2 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Ended earlyNCT03844750
What this trial is testing

Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+2 more
Chloe Atreya, MD, PhD 6
Testing effectiveness (Phase 2)Study completedNCT00557102
What this trial is testing

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute, France 24
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Very early researchEnded earlyNCT00835679
What this trial is testing

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more
National Cancer Institute (NCI) 9
Large-scale testing (Phase 3)Study completedNCT03031444
What this trial is testing

Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis

Who this might be right for
Colorectal Cancer Stage IVMetastasis
Peking University Cancer Hospital & Institute 135
Testing effectiveness (Phase 2)UnknownNCT00513266
What this trial is testing

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
Centre Hospitalier Universitaire Vaudois 35
Large-scale testing (Phase 3)UnknownNCT00002793
What this trial is testing

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Johann Wolfgang Goethe University Hospital 336
Testing effectiveness (Phase 2)Ended earlyNCT00070265
What this trial is testing

Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer

Who this might be right for
Liver MetastasesRecurrent Colon CancerRecurrent Rectal Cancer+2 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)WithdrawnNCT00936832
What this trial is testing

Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
Federation Francophone de Cancerologie Digestive
Very early researchLooking for participantsNCT02172651
What this trial is testing

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Who this might be right for
Stage, Colon CancerStage I-III Colon CancerStage IV Colon Cancer With Resectable Liver Metastases
Dana-Farber Cancer Institute 80
Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Large-scale testing (Phase 3)Ended earlyNCT01189227
What this trial is testing

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
NSABP Foundation Inc 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612007
What this trial is testing

HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverResectable Colorectal Carcinoma+1 more
Mayo Clinic 80
Next Page